Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against Rs 9.40 crore during the previous quarter ended June 2023. Sales rose 33.62% to Rs 244.41 crore in the quarter ended June 2024 as against Rs 182.92 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
Sales | 244.41 | 182.92 | 34 |
OPM % | 13.29 | 12.10 | - |
PBDT | 36.56 | 18.48 | 98 |
PBT | 28.12 | 10.78 | 161 |
NP | 29.35 | 9.40 | 212 |